Immune cells keep tuberculosis bacteria under control by breaking them down. Leiden biologist Annemarie Meijer and her colleagues discovered which protein triggers this process. This protein (DRAM1) is a potential target for new drugs, they write in Cell Host & Microbe.
Source: Universiteit Leiden